Tsann‐Long Su

1.1k citations
63 papers · 851 indexed · h-index 15

Impact in

  • Toxicology top 5%
    • Bioactive Compounds and Antitumor Agents
    • Synthesis and biological activity
    • Synthesis and Biological Evaluation
    • Click Chemistry and Applications
    • Synthesis and Characterization of Heterocyclic Compounds
    • Synthesis and Reactivity of Heterocycles

Papers in

    • Bioactive Compounds and Antitumor Agents 8
    • Synthesis and Biological Evaluation 12
    • Synthesis and biological activity 10
    • Synthesis and Reactivity of Heterocycles 7
    • Synthesis and Characterization of Heterocyclic Compounds 6
    • Click Chemistry and Applications 5

Tsann‐Long Su

61 papers receiving 823 citations

Peers

Tsann‐Long Su
Comparison fields: 5 of 80
  • Toxicology 68
  • Organic Chemistry 461
  • Biochemistry 48
  • Molecular Biology 449
  • Oncology 155
Replace Qizheng Yao with:
Qizheng Yao China
Randall W. Hungate United States
Kohji Akimoto Japan
Süreyya Ölgen Türkiye
Shankar M. Singh Canada
Konrad Misiura Poland
Saeed R. Khan United States
Julie A. Spicer New Zealand
Laurence Goossens France
Chi-Yen Chang Taiwan
Tsann‐Long Su relative to Qizheng Yao China Qizheng Yao's profile →
Citations per field
00.5×1.5×
Qizheng Yao · 1×
Citations per year

Countries citing papers authored by Tsann‐Long Su

Since Specialization
Citations

This map shows the geographic impact of Tsann‐Long Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsann‐Long Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsann‐Long Su more than expected).

Fields of papers citing papers by Tsann‐Long Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsann‐Long Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsann‐Long Su. The network helps show where Tsann‐Long Su may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Tsann‐Long Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tsann‐Long Su Line = papers co-authored together Tsann‐Long Su links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202013
2 20178
3 201631
4 20148
5 201414
6 20149
7 201341
8 201123
9 20111
10 201052
11 200914
12 20086
13 200423
14 20035
15 200212
16 199922
17 19841
18 19829
19 197513
20 19737

About Tsann‐Long Su

Tsann‐Long Su is a scholar working on Toxicology, Organic Chemistry, Biochemistry, Molecular Biology and Pharmacology, having authored 63 papers that have together received 851 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (27 papers), Synthesis and Biological Evaluation (12 papers), Synthesis and biological activity (10 papers), Bioactive Compounds and Antitumor Agents (8 papers), Synthesis and Reactivity of Heterocycles (7 papers), Synthesis and Characterization of Heterocyclic Compounds (6 papers), Click Chemistry and Applications (5 papers) and Botanical Research and Chemistry (4 papers). The work is most often cited by research in Toxicology (68 citations), Organic Chemistry (461 citations), Biochemistry (48 citations), Molecular Biology (449 citations) and Oncology (155 citations). Tsann‐Long Su has collaborated with scholars based in Taiwan, United States and India. Frequent co-authors include Te‐Chang Lee, Ting‐Chao Chou, Rajesh Kakadiya, Kyoichi A. Watanabe, Jack J. Fox, Wen‐Chi Su, Tzu‐Ping Ko, Sheng‐Teh Lu, Frederick S. Philips and Yi‐Wen Lin. Their work appears in journals such as European Journal of Medicinal Chemistry, Oncotarget, Journal of Medicinal Chemistry, Cancer Research and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026